Novel Target Identification & Validation Using Complex in vitro Models & Computational Biology in NASH.

Time: 2:00 pm
day: Day 1 Stream 1 PM


• Capturing critical pathophysiologic drivers of NASH to recapitulate human disease in vitro
• Utilizing diverse computational biology approaches to identify novel targets
• Validating and systematically rank targets for pipeline decision-making and prioritization Ryan Feaver, Program Director, HemoShear Therapeutics